No abstract

The problems of the resistance of pathogenic bacteria to the common antibiotics in hospitals and the high costs of the treatments of pathologies due to those resistant bacteria have brought about innovation in the search for alternative treatments: plants. The purpose of this study is to assess the antibacterial activities of the aqueous and hydroethanolic extracts from the leaves of Erythrococca anomala on the in vitro growth of six multiresistant bacterial strains such as: Pseudomonas aeruginosa, Escherichia coli Klebsiella pneumoniae, Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus. They were isolated from patients. The results of the studies showed that the aqueous extract, being more active than the hydroethanolic extract, contains Minimal Inhibitory Concentrations (MICs) which vary between 0.78 mg/mL and 12.5, whereas the Minimal Bactericidal Concentrations (MBCs) vary between 0.78 mg/mL and 25 mg/mL. Concerning the hydroethanolic extract, the MICs and the MBCs vary between 3.125 mg/mL and 25 mg/mL respectively. Streptococcus pneumoniae and Staphylococcus aureus are more susceptible because they need 0.78 mg/mL and 1.56 mg/mL respectively before they are completely inhibited by the aqueous extract. Compared with the Ciprofloxacin, a pure molecule, those extracts have clearly better antibacterial activity. That may justify why those leaves are used in traditional areas as anti-infectious treatment. Erythrococca anomala is a glimmer of hope for the treatment of infectious diseases in Côte d'Ivoire.

No abstract

This study was conducted to evaluate Trema guineensis leaves efficacy in preventing CCl

No abstract